The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy

West Indian Medical Journal

Volumn 56, Issue 3, 2007, Pages 270-274

  Williams, M ^a   Clarke, T ^a   Williams, P ^b   Barton, E N ^a  

^a UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF TECHNOLOGY   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CARIBBEAN ISLANDS; CONTROLLED STUDY; DOSE CALCULATION; DRUG TREATMENT FAILURE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; SELF REPORT; SOCIAL WORKER; TREATMENT DURATION; UNIVERSITY HOSPITAL; VIRUS RESISTANCE;

EID: 36749097794     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0043-31442007000300016     Document Type: Article

References (10)

1. Vincke J, Bolton R. Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information. AIDS Patient Care STDS 2002; 16: 487-95.
2. Hardy H. Adherence to antiretroviral therapy: The emerging role of HIV pharmacotherapy specialists. J Pharm Prac 2005; 18: 247-57.
3. Cinti S K. Adherence to antiretrovirals in HIV disease. AIDS Read 2000; 10: 709-17.
4. Stone VE. Monitoring and measuring adherence to HAART in clinical practice. Medscape General Medicine 2002; 4(3). Available at: http://www.medscape.com/voewartoce/438193_5. Accessed March 21, 2006.
5. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquired Immune Defic Syndr 2005; 38: 445-8.
6. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999 Jun 18; 13: 1099-107.
7. Paterson D L, Swindells S, Mohr J, Brester M, Vergis E N, Squier C et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
8. Liu H, Golin CE, Miller LG, Hays R D, Beck CK, Sanandaji S et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134: 968-77.
9. Murri R, Ammassari A, Trotta W, De Luca A, Melzi S, Minardi C et al. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. J Gen Intern Med 2004; 19: 1104-10.
10. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S et al. Adherence to antiretroviral therapy in Sub-Saharan Africa and North America: A meta-anaiysis. JAMA 2006; 296: 679-90.